ARDS (Moderate or Severe)
11 clinical trials · Condition
◉ Watch ARDS (Moderate or Severe)
| Record | Firm | Date |
|---|---|---|
| Multiple Dosing of Mesenchymal Stromal Cells in Patients With ARDS (COVID-19) (NCT04466098) | Masonic Cancer Center, University of Minnesota | 2020-07-30 |
Track ARDS (Moderate or Severe) automatically
Every clearance here is in the API, with alerts when new ones post.